Meta-analysed numbers needed to treat of novel antidiabetic drugs for cardiovascular outcomes.
ESC heart failure(2023)
Abstract
We found only modest treatment benefits of GLP-1 receptor agonists and SGLT2 inhibitors for CM and HHF in primary type 2 diabetes mellitus populations. In primary heart failure populations, SGLT2 inhibitor benefits were substantial and comparable in efficacy to established heart failure medication.
MoreTranslated text
Key words
Absolute treatment effect,GLP-1 receptor agonist,Heart failure,Meta-analysis,Number needed to treat,SGLT2 inhibitor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined